Of course, RGS1 is down-regulated in some tumors such as bladder cancer, rectum adenocarcinoma, and thyroid carcinoma (from TCGA databank), which can interfere with its use as a biomarker for the diagnosis of OTB. Here, RGS1 is linked to urinary bladder cancer.